PATENT CLAIM ANALYSIS

Application Number: 15562825
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-04
Patent Classification: ["544", "183000"]

Abstract:
The present invention relates to a tyrosine kinase inhibitor and a pharmaceutical composition comprising same. The tyrosine kinase inhibitor of the present invention has the structures as shown in the following formula (I) or (II):

Claim (Index 22):
A compound or an enantiomer, a diastereomer, a geometric isomer, a solvate or a pharmaceutically acceptable salt thereof according to  claim 18 , wherein R 1  is selected from C 1-6  alkoxy, O(CH 2 ) n R 1d1  and wherein n is an integer of 1 to 6, R 1d1  is C 1-6  alkoxy or NR 1d5 R 1d6 , wherein, R 1d5  and R 1d6  are each independently H or C 1-6  alkyl, R 1d2 , R 1d3  and R 1d4  are each independently H, C 1-6  alkyl or aryl; R 2  is selected from H, CN, halo C 1-3  alkyl, hydroxy C 1-3  hydroxy, \u2014C(\u2550O)N(R 2d1 )(R 2d2 ), \u2014N(R 2d1 )C(\u2550O)R 2d2  and \u2014C(\u2550O)OR 2d3 .

Metadata:
- Claim Count in Document: 56.0
- Percentile: 94.0
- Lexical Diversity: 1.36667
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15812142', '15750704', '16470111', '15314599', '16326976']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8171798762131582
- 35 USC 102 Novelty (BERT): 0.5339319807598272
- Combined Prediction Score: 0.7888550866678252
- Mean Citation Score: 357.22619
- Max Citation Score: 380.52487
- Similarity Product: 272.9251990459168

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test